Updates

Duncan NRI News

News Release Ago. 18, 2021

McGinley lab featured in the Wall Street Journal

Health Briefs Dic. 08, 2020

Duncan NRI 10th Anniversary

News Release Sep. 29, 2019

Deep brain stimulation can correct neural malfunction in Rett and MeCP2 duplication syndrome mice

Health Briefs May. 21, 2019

McGinley And Arenkiel Involved In An Exciting DARPA-Funded Project

Health Briefs May. 21, 2019

McGinley Involved In An Exciting DARPA-Funded Project

Awards Abr. 22, 2019

McGinley Receives John S. Dunn Research Collaborative Award

Patient Stories Sep. 17, 2018

Leo the Superhero

Patient Stories Jul. 18, 2018

Tumor Resection Surgery Curbed Hailey's Seizures

News Release Jun. 20, 2018

A new integrative approach finds viable therapeutic targets for Huntington's disease

News Release Abr. 20, 2018

FDA Approves Everolimus For Tuberous Sclerosis-Associated Seizures, A Treatment First Discovered At Texas Children’s Hospital

News Release Mar. 07, 2018

The Dystonia Medical Research Foundation interviews Dr. Roy Sillitoe

Patient Stories Mar. 02, 2018

Former British Prime Minister Shares The Lessons He Learnt From His Son's Rare Epileptic Syndrome

News Release Dic. 06, 2017

NRI researchers identify a promising drug target for childhood brain tumors

Health Briefs Dic. 05, 2017

A drug originally identified by Cain Lab researchers approved by EU for partial-onset seizures in Tuberous Sclerosis patients

Health Briefs Sep. 08, 2017

Dr. Wu Chen wins the 2017 American Epilepsy Society's Young Investigator Award

News Release Sep. 04, 2017

New study reveals potential drug targets for MECP2 duplication and Rett syndromes

Health Briefs Ago. 16, 2017

CDC finds an increase in epilepsy among Americans

News Release Ago. 02, 2017

A potential therapeutic target for juvenile Batten disease

Health Briefs May. 04, 2017

Cain Lab researcher receives a fellowship from the American Epilepsy Society

Patient Stories Abr. 07, 2017

Aiden's Story — Tuberous sclerosis complex